Saturday, October 3, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 11, 2026

Exodus Reports First Quarter 2026 Results

View original at globenewswire.com
“Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the first quarter ended March 31, 2026. ... Net loss $(32.1) [in USD millions for Q1 2026]”
Verbatim excerpt from the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Net loss in Q1 2026 was $32.1 million, compared to $12.9 million in Q1 2025, a 149% increase in losses year-over-year

    60% confidence

  • Exchange provider processed volume was $1.18 billion in Q1 2026, down 26% from Q4 2025

    60% confidence

  • Top assets traded in Q1 2026 were Bitcoin (29%), Tether TRX Network (14%), Tether ETH Network (11%), ETH (9%), and USDC ETH Network (7%) of volume

    60% confidence

  • Quarterly funded users were 1.4 million at end of Q1 2026, down 18% from 1.7 million as of December 31, 2025

    60% confidence

  • XO Swap's share of exchange volume has grown steadily since launch, reflecting demand for best-execution routing across liquidity sources

    60% confidence

  • B2B swap partners generated $257 million in Q1 2026 volume, representing 22% of the quarterly total exchange volume

    60% confidence

  • Monavate and Baanx are established providers of card and payments infrastructure, serving fintech, crypto, and enterprise clients worldwide

    60% confidence

  • Total digital assets, cash, and cash equivalents were $122.6 million as of March 31, 2026, including $42.8M Bitcoin, $3.9M Ether, and $74.4M cash, cash equivalents, and stablecoins

    60% confidence

  • Full-time equivalent team members were approximately 220 as of March 31, 2026, up 5 from December 31, 2025

    60% confidence

  • Exodus monthly active users were 1.5 million as of March 31, 2026, unchanged from December 31, 2025

    60% confidence

  • General and administrative expense was $15.5 million in Q1 2026, up 8% from $14.3 million in Q1 2025

    60% confidence

  • Loss on digital assets, net was $36.4 million in Q1 2026, compared to $28.8 million in Q1 2025, a 26% increase

    60% confidence

  • Average customer response time was less than 60 minutes in Q1 2026

    60% confidence

  • Technology, development and user support expense was $16.2 million in Q1 2026, up 9% from $14.9 million in Q1 2025

    60% confidence

  • Q1 2026 revenue was $22.7 million, down 37% from $36.0 million in Q1 2025

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com